Plain-English translation of NCT06402747 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether two medications — or — can help prevent blood vessels from becoming clogged in people with type 2 diabetes. Researchers will compare how well each medication slows down the buildup of plaque in the neck arteries (a condition called atherosclerosis) and how it affects blood flow. The goal is to find out if either of these medications can protect your heart and blood vessels before serious problems happen.
People with type 2 diabetes are at high risk for heart disease and clogged arteries, which can lead to stroke and other life-threatening complications. While these two medications are currently used to treat patients who already have symptoms, doctors don't yet know if they can prevent these problems from developing in the first place.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either (75 mg once daily) or (200 mg daily). You will visit the study center for check-ups where doctors will use ultrasound to measure your neck arteries and monitor your blood flow over time. The study will track how well the medication works to slow or stop the buildup of plaque and how it affects your overall heart health.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea